Long-term effects of laparoscopic Roux-en-Y gastric bypass on metabolic syndrome in patients with morbid obesity

Surgery for Obesity and Related Diseases

Volumn 12, Issue 8, 2016, Pages 1449-1456

  Shah, Kamran ^a   Johnny Nergard, Bent ^a   Stray Frazier, Katinka ^a   Geir Leifsson, Björn ^a   Aghajani, Ebrahim ^a   Gislason, Hjörtur ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Metabolic syndrome; Remission; Roux en Y gastric bypass

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GASTRIC BYPASS SURGERY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INTERNAL HERNIA; INTESTINE OBSTRUCTION; LAPAROSCOPIC SURGERY; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; PULMONARY ASPIRATION; REMISSION; RETROSPECTIVE STUDY; SLEEP DISORDERED BREATHING; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; ADOLESCENT; ARTHRALGIA; COMPLICATION; DIABETES MELLITUS, TYPE 2; LAPAROSCOPY; METABOLISM; MIDDLE AGED; OBESITY, MORBID; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROCEDURES; PROSPECTIVE STUDY; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ARTHRALGIA; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRIC BYPASS; HUMANS; HYPERTENSION; LAPAROSCOPY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, MORBID; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME; TRIGLYCERIDES; WEIGHT LOSS; YOUNG ADULT;

EID: 84998842321     PISSN: 15507289     EISSN: 18787533     Source Type: Journal    
DOI: 10.1016/j.soard.2016.03.017     Document Type: Article

References (35)

1. [1] Finucane, M.M., Stevens, G.A., Cowan, M.J., et al. Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index). National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants. Lancet 377:9765 (2011), 557–567.
2. [2] Alberti, K.G., Eckel, R.H., Grundy, S.M., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:16 (2009), 1640–1645.
3. [3] Alberti, K.G., Zimmet, P., Shaw, J., et al. The metabolic syndrome—a new worldwide definition. Lancet 366:9491 (2005), 1059–1062.
4. [4] Park, Y.W., Zhu, S., Palaniappan, L., et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 163:4 (2003), 427–436.
5. [5] Hildrum, B., Mykletun, A., Hole, T., et al. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health, 7, 2007, 220.
6. [6] Purnell, J.Q., Selzer, F., Smith, M.D., et al. Metabolic syndrome prevalence and associations in a bariatric surgery cohort from the Longitudinal Assessment of Bariatric Surgery-2 study. Metab Syndr Relat Disord 12:2 (2014), 86–94.
7. [7] Isomaa, B., Almgren, P., Tuomi, T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:4 (2001), 683–689.
8. [8] Sundstrom, J., Riserus, U., Byberg, L., et al. Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. BMJ 332:7546 (2006), 878–882.
9. [9] Batsis, J.A., Romero-Corral, A., Collazo-Clavell, M.L., et al. Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study. Mayo Clin Proc 83:8 (2008), 897–907.
10. [10] Buchwald, H., Avidor, Y., Braunwald, E., et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 292:14 (2004), 1724–1737.
11. [11] Adams, T.D., Gress, R.E., Smith, S.C., et al. Long-term mortality after gastric bypass surgery. N Engl J Med 357:8 (2007), 753–761.
12. [12] Eliasson, B., Liakopoulos, V., Franzén, S., et al. Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in Sweden: a nationwide, matched, observational cohort study. Lancet Diabetes Endocrinol 3:11 (2015), 847–854.
13. [13] Buse, J.B., Caprio, S., Cefalu, W.T., et al. How do we define cure of diabetes?. Diabetes Care 32:11 (2009), 2133–2135.
14. [14] Haffner, S.M., American Diabetes Association. Dyslipidemia management in adults with diabetes. Diabetes Care 27:Suppl 1 (2004), S68–S71.
15. [15] Jacobsen, H.J., Bergland, A., Raeder, J., et al. High-volume bariatric surgery in a single center: safety, quality, cost-efficacy and teaching aspects in 2,000 consecutive cases. Obes Surg 22:1 (2012), 158–166.
16. [16] Aghajani, E., Jacobsen, H.J., Nergaard, B.J., et al. Internal hernia after gastric bypass: a new and simplified technique for laparoscopic primary closure of the mesenteric defects. J Gastrointest Surg 16:3 (2012), 641–645.
17. [17] Fried, M., Hainer, V., Basdevant, A., et al. Interdisciplinary European Guidelines on Surgery of Severe Obesity. Obesity Facts 1:1 (2008), 52–59.
18. [18] Ricci, C., Gaeta, M., Rausa, E., et al. Long-term effects of bariatric surgery on type II diabetes, hypertension and hyperlipidemia: a meta-analysis and meta-regression study with 5-year follow-up. Obes Surg 25:3 (2015), 397–405.
19. [19] Schauer, P.R., Kashyap, S.R., Wolski, K., et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 366:17 (2012), 1567–1576.
20. [20] Mingrone, G., Panunzi, S., De Gaetano, A., et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 366 (2012), 1577–1585.
21. [21] Adams, T.D., Davidson, L.E., Litwin, S.E., et al. Health benefits of gastric bypass surgery after 6 years. JAMA 308 (2012), 1122–1131.
22. [22] Chikunguwo, S.M., Wolfe, L.G., Dodson, P., et al. Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surg Obes Relat Dis 6 (2010), 254–259.
23. [23] Puzziferri, N., Roshek, T.B., Mayo, H.G., et al. Long-term follow-up after bariatric surgery: a systematic review. JAMA 312:9 (2014), 934–942.
24. [24] Ties, J.S., Zlabek, J.A., Kallies, K.J., et al. The effect of laparoscopic gastric bypass on dyslipidemia in severely obese patients: a 5-year follow-up analysis. Obes Surg 24 (2014), 549–553.
25. [25] Laurino Neto, R.M., Herbella, F.A., Tauil, R.M., et al. Comorbidities remission after Roux-en-Y gastric bypass for morbid obesity is sustained in a long-term follow-up and correlates with weight regain. Obes Surg 22 (2012), 1580–1585.
26. [26] Kannel, W.B., Range of serum cholesterol values in the population developing coronary artery disease. Am J Cardiol 76:9 (1995), 69C–77C.
27. [27] Koenig, W., Sund, M., Fröhlich, M., et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99:2 (1999), 237–242.
28. [28] Gregor, M.F., Hotamisligil, G.S., Inflammatory mechanisms in obesity. Annu Rev Immunol 29 (2011), 415–445.
29. [29] Esser, N., Legrand-Poels, S., Piette, J., et al. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract 105:2 (2014), 141–150.
30. [30] Ortega, F.J., Vilallonga, R., Xifra, G., et al. Bariatric surgery acutely changes the expression of inflammatory and lipogenic genes in obese adipose tissue. Surg Obes Relat Dis 12:2 (2016), 357–362.
31. [31] Forsythe, L.K., Wallace, J.M., Livingstone, M.B., Obesity and inflammation: the effects of weight loss. Nutr Res Rev 21:2 (2008), 117–133.
32. [32] Sparks, J.A., Halperin, F., Karlson, J.C., et al. Impact of bariatric surgery on patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) 67:12 (2015), 1619–1626.
33. [33] Nugent, C., Bai, C., Elariny, H., et al. Metabolic syndrome after laparoscopic bariatric surgery. Obes Surg 18 (2008), 1278–1286.
34. [34] Chang, S.H., Stoll, C.R., Song, J., et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg 149:3 (2014), 275–287.
35. [35] Cummings, D.E., Cohen, R.V., Beyond BMI: the need for new guidelines governing the use of bariatric and metabolic surgery. Lancet Diabetes Endocrinol 2:2 (2014), 175–181.